Symbols / BLRX Stock $2.27 -1.30% BioLineRx Ltd.

Healthcare • Biotechnology • Israel • NCM
BLRX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Philip A. Serlin CPA, M.B.A.
Exch · Country NCM · Israel
Market Cap 10.21M
Enterprise Value 5.92B
Income -1.18M
Sales 1.18M
FCF (ttm) -3.88M
Book/sh 4.20
Cash/sh 0.01
Employees 20
Insider 10d —
IPO Jul 27, 2011
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E inf
Forward P/E -3.39
PEG —
P/S 8.66
P/B 0.54
P/C —
EV/EBITDA -588.57
EV/Sales 5,017.77
Quick Ratio 1.76
Current Ratio 1.95
Debt/Eq 43.48
LT Debt/Eq —
EPS (ttm) 0.00
EPS next Y -0.67
EPS Growth —
Revenue Growth -98.30%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-27
Earnings (prior) 2026-03-23
ROA -16.11%
ROE -11.01%
ROIC —
Gross Margin 80.51%
Oper. Margin -17.45%
Profit Margin -99.58%
Shs Outstand 4.35M
Shs Float 2.50B
Insider Own 4.00%
Instit Own 1.10%
Short Float 3.56%
Short Ratio 8.90
Short Interest 154.75K
52W High 7.77
vs 52W High -70.79%
52W Low 2.15
vs 52W Low 5.58%
Beta 0.48
Impl. Vol. 0.00%
Rel Volume 0.82
Avg Volume 13.70K
Volume 11.28K
Target (mean) $17.50
Tgt Median $17.50
Tgt Low $12.00
Tgt High $23.00
# Analysts 2
Recom Strong_buy
Prev Close $2.30
Price $2.27
Change -1.30%
About

BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$17.50
Mean price target
2. Current target
$2.27
Latest analyst target
3. DCF / Fair value
$-16.03
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.27
Low
$12.00
High
$23.00
Mean
$17.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-06-17 reit HC Wainwright & Co. Buy → Buy $26
2025-05-30 up Jones Trading Hold → Buy $12
2025-05-28 reit HC Wainwright & Co. Buy → Buy $26
2025-04-02 down Jones Trading Buy → Hold —
2025-03-31 main HC Wainwright & Co. Buy → Buy $26
2024-11-25 main HC Wainwright & Co. Buy → Buy $9
2024-11-06 reit HC Wainwright & Co. Buy → Buy $21
2024-06-03 reit HC Wainwright & Co. Buy → Buy $21
2024-05-29 reit HC Wainwright & Co. Buy → Buy $21
2024-04-17 reit HC Wainwright & Co. Buy → Buy $21
2024-03-26 reit HC Wainwright & Co. Buy → Buy $21
2024-02-29 reit HC Wainwright & Co. Buy → Buy $21
2023-11-20 reit HC Wainwright & Co. Buy → Buy $21
2023-09-15 main HC Wainwright & Co. Buy → Buy $21
2023-08-31 reit HC Wainwright & Co. Buy → Buy $19
2023-05-25 reit Oppenheimer — → Outperform $4
2021-02-23 main HC Wainwright & Co. — → Buy $19
2020-12-16 main HC Wainwright & Co. — → Buy $22
2017-08-04 init Oppenheimer — → Outperform $3
2017-05-18 up Maxim Group Hold → Buy —
News
RSS: Latest BLRX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1.18
-95.92%
28.94
+502.92%
4.80
0.00
Operating Revenue
1.18
-95.92%
28.94
+502.92%
4.80
0.00
Cost Of Revenue
0.23
-97.52%
9.26
+150.89%
3.69
0.00
Reconciled Cost Of Revenue
0.23
-95.85%
5.54
+108.27%
2.66
0.00
Gross Profit
0.95
-95.17%
19.68
+1675.90%
1.11
0.00
Operating Expense
11.24
-71.06%
38.83
-11.95%
44.10
+51.25%
29.16
Research And Development
8.09
-11.54%
9.15
-26.92%
12.52
-28.99%
17.63
Selling General And Administration
3.92
-86.28%
28.54
-8.61%
31.23
+171.82%
11.49
Selling And Marketing Expense
0.00
-100.00%
10.08
-30.92%
14.59
+198.89%
4.88
General And Administrative Expense
3.92
-78.79%
18.46
+10.96%
16.64
+151.81%
6.61
Salaries And Wages
1.70
-88.60%
14.91
+19.10%
12.52
+241.97%
3.66
Other Gand A
1.61
-41.20%
2.75
-13.73%
3.18
+67.39%
1.90
Total Expenses
11.47
-76.16%
48.09
+0.63%
47.79
+63.91%
29.16
Operating Income
-10.29
+46.29%
-19.15
+55.45%
-42.99
-47.45%
-29.16
Total Operating Income As Reported
-10.29
+49.59%
-20.41
+58.93%
-49.69
-70.44%
-29.16
EBITDA
-0.25
-106.43%
3.92
+106.86%
-57.09
-153.59%
-22.51
Normalized EBITDA
-9.19
+33.60%
-13.84
+64.86%
-39.39
-37.78%
-28.59
Reconciled Depreciation
0.52
-87.13%
4.07
+193.71%
1.38
+111.62%
0.65
EBIT
-0.78
-427.21%
-0.15
+99.75%
-58.47
-152.41%
-23.16
Total Unusual Items
8.94
-49.67%
17.76
+200.36%
-17.70
-391.10%
6.08
Total Unusual Items Excluding Goodwill
8.94
-49.67%
17.76
+200.36%
-17.70
-391.10%
6.08
Special Income Charges
0.00
+100.00%
-1.26
+81.26%
-6.70
0.00
Other Special Charges
—
0.25
—
—
Impairment Of Capital Assets
0.00
-100.00%
1.01
-84.93%
6.70
0.00
Net Income
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Pretax Income
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Non Operating Interest Income Expense
-0.16
+97.86%
-7.30
-4405.56%
-0.16
+85.51%
-1.12
Interest Expense Non Operating
1.25
-86.21%
9.07
+323.23%
2.14
+20.04%
1.79
Net Interest Income
-0.16
+97.86%
-7.30
-4405.56%
-0.16
+85.51%
-1.12
Interest Expense
1.25
-86.21%
9.07
+323.23%
2.14
+20.04%
1.79
Interest Income Non Operating
1.12
-38.24%
1.82
-9.32%
2.01
+189.19%
0.69
Interest Income
1.12
-38.24%
1.82
-9.32%
2.01
+189.19%
0.69
Other Income Expense
8.42
-51.15%
17.23
+198.68%
-17.46
-427.97%
5.32
Other Non Operating Income Expenses
-0.52
+1.51%
-0.53
-325.53%
0.23
+131.13%
-0.76
Gain On Sale Of Security
8.94
-52.99%
19.02
+272.98%
-10.99
-280.84%
6.08
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Income From Continuing Operation Net Minority Interest
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Income From Continuing And Discontinued Operation
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Net Income Continuous Operations
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Minority Interests
0.85
—
—
—
Normalized Income
-10.11
+62.51%
-26.98
+37.13%
-42.92
-38.31%
-31.03
Net Income Common Stockholders
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Diluted EPS
0.00
+100.00%
-6.00
+83.33%
-36.00
-100.00%
-18.00
Basic EPS
0.00
+100.00%
-6.00
+83.33%
-36.00
-100.00%
-18.00
Basic Average Shares
4.11
+105.76%
2.00
+24.37%
1.61
+24.47%
1.29
Diluted Average Shares
4.11
+105.76%
2.00
+24.37%
1.61
+24.47%
1.29
Diluted NI Availto Com Stockholders
-1.18
+87.26%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Depreciation Amortization Depletion Income Statement
0.03
-91.76%
0.34
-3.13%
0.35
+800.00%
0.04
Depreciation And Amortization In Income Statement
0.03
-91.76%
0.34
-3.13%
0.35
+800.00%
0.04
Depreciation Income Statement
0.03
-91.76%
0.34
-3.13%
0.35
+800.00%
0.04
Insurance And Claims
0.60
-25.37%
0.81
-13.95%
0.94
-10.23%
1.05
Provision For Doubtful Accounts
-0.80
-200.00%
0.80
0.00
0.00
Total Other Finance Cost
0.03
-35.56%
0.04
+80.00%
0.03
-3.85%
0.03
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
40.91
+5.14%
38.91
-39.14%
63.92
-16.31%
76.38
Current Assets
23.68
-12.63%
27.10
-42.56%
47.18
-9.27%
52.00
Cash Cash Equivalents And Short Term Investments
20.88
+6.72%
19.56
-54.50%
42.99
-15.83%
51.08
Cash And Cash Equivalents
3.25
-68.86%
10.44
+145.26%
4.25
-59.81%
10.59
Cash Equivalents
2.62
-72.42%
9.49
+762.13%
1.10
-84.19%
6.96
Cash Financial
0.63
-33.05%
0.94
-70.07%
3.15
-12.95%
3.62
Other Short Term Investments
17.63
+93.14%
9.13
-76.44%
38.74
-4.34%
40.49
Receivables
0.46
-88.20%
3.86
+445.62%
0.71
-1.80%
0.72
Accounts Receivable
0.05
-98.14%
2.48
+591.62%
0.36
0.00
Other Receivables
0.41
-70.44%
1.39
+296.29%
0.35
-51.46%
0.72
Inventory
2.15
-31.70%
3.15
+61.03%
1.95
0.00
Raw Materials
—
0.00
-100.00%
0.90
0.00
Work In Process
—
2.98
+532.70%
0.47
0.00
Finished Goods
—
0.17
-71.50%
0.58
0.00
Prepaid Assets
0.20
-62.36%
0.53
-65.05%
1.53
+671.72%
0.20
Total Non Current Assets
17.22
+45.94%
11.80
-29.51%
16.74
-31.34%
24.38
Net PPE
0.86
-36.73%
1.35
-28.34%
1.89
-24.42%
2.50
Gross PPE
5.96
-5.91%
6.33
-14.75%
7.43
+2.03%
7.28
Accumulated Depreciation
-5.10
-2.47%
-4.98
+10.13%
-5.54
-15.85%
-4.78
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.80
-31.86%
1.17
-30.20%
1.68
+9.15%
1.54
Other Properties
1.57
+0.00%
1.57
-2.60%
1.61
+0.44%
1.61
Leases
3.59
+0.00%
3.59
-13.21%
4.13
+0.00%
4.13
Goodwill And Other Intangible Assets
16.37
+56.65%
10.45
-29.66%
14.85
-32.13%
21.89
Other Intangible Assets
16.37
+56.65%
10.45
-29.66%
14.85
-32.13%
21.89
Total Liabilities Net Minority Interest
17.56
-30.99%
25.45
-49.81%
50.70
+98.50%
25.54
Current Liabilities
12.12
-21.31%
15.41
-63.99%
42.78
+300.64%
10.68
Payables And Accrued Expenses
4.93
-40.53%
8.28
-39.99%
13.80
+65.64%
8.33
Payables
4.03
-27.80%
5.58
-49.05%
10.96
+55.42%
7.05
Accounts Payable
3.49
-37.44%
5.58
-48.63%
10.87
+56.03%
6.97
Other Payable
0.54
—
0.09
+4.76%
0.08
Current Accrued Expenses
0.90
-66.85%
2.70
-5.13%
2.85
+121.82%
1.28
Pensionand Other Post Retirement Benefit Plans Current
0.31
-28.07%
0.43
+2.86%
0.42
+11.14%
0.38
Current Debt And Capital Lease Obligation
4.71
-5.76%
5.00
+36.16%
3.67
+86.54%
1.97
Current Debt
4.48
+0.00%
4.48
+42.42%
3.15
+103.96%
1.54
Other Current Borrowings
4.48
+0.00%
4.48
+42.42%
3.15
+103.96%
1.54
Current Capital Lease Obligation
0.23
-55.17%
0.52
-1.14%
0.53
+23.65%
0.43
Current Deferred Liabilities
—
0.00
-100.00%
12.96
0.00
Current Deferred Revenue
—
0.00
-100.00%
12.96
0.00
Other Current Liabilities
2.17
+28.56%
1.69
-85.83%
11.93
—
Total Non Current Liabilities Net Minority Interest
5.44
-45.84%
10.04
+26.79%
7.92
-46.73%
14.86
Long Term Debt And Capital Lease Obligation
5.44
-45.84%
10.04
+26.79%
7.92
-23.53%
10.36
Long Term Debt
4.46
-50.21%
8.96
+35.15%
6.63
-23.16%
8.63
Long Term Capital Lease Obligation
0.98
-9.62%
1.08
-16.20%
1.29
-25.39%
1.73
Stockholders Equity
18.20
+35.18%
13.46
+1.80%
13.22
-73.99%
50.84
Common Stock Equity
18.20
+35.18%
13.46
+1.80%
13.22
-73.99%
50.84
Capital Stock
73.43
+92.74%
38.10
+21.50%
31.36
+15.70%
27.10
Common Stock
73.43
+92.74%
38.10
+21.50%
31.36
+15.70%
27.10
Share Issued
2,610.81
+95.32%
1,336.67
+23.02%
1,086.59
+17.73%
922.96
Ordinary Shares Number
2,610.81
+95.32%
1,336.67
+23.02%
1,086.59
+17.73%
922.96
Additional Paid In Capital
327.58
-7.38%
353.69
-0.50%
355.48
+4.87%
338.98
Retained Earnings
-401.00
-0.29%
-399.83
-2.36%
-390.61
-18.37%
-329.99
Gains Losses Not Affecting Retained Earnings
14.50
-10.11%
16.13
+3.51%
15.58
+16.74%
13.35
Minority Interest
5.15
0.00
—
—
Other Equity Adjustments
14.50
-10.11%
16.13
+3.51%
15.58
+16.74%
13.35
Total Equity Gross Minority Interest
23.34
+73.43%
13.46
+1.80%
13.22
-73.99%
50.84
Total Capitalization
22.66
+1.06%
22.42
+12.94%
19.85
-66.62%
59.47
Working Capital
11.56
-1.20%
11.70
+165.92%
4.40
-89.35%
41.32
Invested Capital
27.14
+0.88%
26.90
+16.97%
23.00
-62.31%
61.01
Total Debt
10.15
-32.51%
15.04
+29.76%
11.59
-5.95%
12.32
Net Debt
5.69
+89.57%
3.00
-45.61%
5.52
—
Capital Lease Obligations
1.21
-24.45%
1.60
-11.83%
1.82
-15.68%
2.16
Net Tangible Assets
1.83
-39.31%
3.01
+284.67%
-1.63
-105.63%
28.96
Tangible Book Value
1.83
-39.31%
3.01
+284.67%
-1.63
-105.63%
28.96
Derivative Product Liabilities
—
—
11.93
+164.63%
4.51
Other Equity Interest
3.69
-31.32%
5.37
+281.18%
1.41
+0.00%
1.41
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.07
+81.60%
-43.87
-94.06%
-22.61
+13.84%
-26.24
Cash Flow From Continuing Operating Activities
-8.07
+81.60%
-43.87
-94.06%
-22.61
+13.84%
-26.24
Net Income From Continuing Operations
-2.03
+78.03%
-9.22
+84.79%
-60.61
-142.93%
-24.95
Depreciation Amortization Depletion
0.52
-87.13%
4.07
+193.71%
1.38
+111.62%
0.65
Depreciation And Amortization
0.52
-87.13%
4.07
+193.71%
1.38
+111.62%
0.65
Other Non Cash Items
0.02
+101.91%
-0.94
-180.91%
1.16
+161.35%
0.45
Stock Based Compensation
0.40
-65.11%
1.14
-51.10%
2.32
+3.39%
2.25
Asset Impairment Charge
0.00
-100.00%
1.26
-81.26%
6.70
0.00
Operating Gains Losses
-8.24
+55.07%
-18.35
-263.31%
11.24
+291.38%
-5.87
Gain Loss On Investment Securities
-7.90
+56.84%
-18.30
-265.51%
11.05
+276.75%
-6.25
Net Foreign Currency Exchange Gain Loss
-0.37
-601.89%
-0.05
-129.12%
0.18
-52.48%
0.38
Gain Loss On Sale Of PPE
0.03
0.00
0.00
—
Change In Working Capital
1.26
+105.77%
-21.82
-243.55%
15.20
+1127.71%
1.24
Change In Receivables
2.43
+214.73%
-2.12
-491.62%
-0.36
0.00
Changes In Account Receivables
2.43
+214.73%
-2.12
-491.62%
-0.36
0.00
Change In Inventory
1.00
+183.64%
-1.19
+38.97%
-1.95
0.00
Change In Prepaid Assets
1.31
+3146.51%
-0.04
+95.52%
-0.96
-47.54%
-0.65
Change In Payables And Accrued Expense
-3.48
+36.86%
-5.51
-199.93%
5.51
+191.95%
1.89
Change In Other Working Capital
—
-12.96
-200.00%
12.96
—
Investing Cash Flow
-8.54
-129.09%
29.37
+1934.21%
1.44
-63.95%
4.01
Cash Flow From Continuing Investing Activities
-8.54
-129.09%
29.37
+1934.21%
1.44
-63.95%
4.01
Net PPE Purchase And Sale
-0.03
+52.83%
-0.05
+54.31%
-0.12
+11.45%
-0.13
Purchase Of PPE
-0.03
+52.83%
-0.05
+54.31%
-0.12
+11.45%
-0.13
Capital Expenditure
-0.03
+50.00%
-0.05
+81.82%
-0.30
+6.01%
-0.32
Net Investment Purchase And Sale
-8.52
-128.95%
29.43
+1590.29%
1.74
-59.72%
4.32
Purchase Of Investment
-36.64
-39.07%
-26.35
+44.63%
-47.59
-8.15%
-44.00
Sale Of Investment
28.13
-49.58%
55.78
+13.07%
49.33
+2.08%
48.32
Net Intangibles Purchase And Sale
-0.00
-100.00%
-0.00
+99.45%
-0.18
+2.16%
-0.18
Purchase Of Intangibles
-0.00
-100.00%
-0.00
+99.45%
-0.18
+2.16%
-0.18
Financing Cash Flow
8.88
-56.99%
20.66
+37.21%
15.06
-26.33%
20.44
Cash Flow From Continuing Financing Activities
8.88
-56.99%
20.66
+37.21%
15.06
-26.33%
20.44
Net Issuance Payments Of Debt
-5.01
-217.08%
4.28
+315.24%
-1.99
-132.73%
6.07
Issuance Of Debt
0.00
-100.00%
19.22
0.00
-100.00%
9.13
Repayment Of Debt
-5.01
+66.47%
-14.94
-651.71%
-1.99
+34.86%
-3.05
Long Term Debt Issuance
0.00
-100.00%
19.22
0.00
-100.00%
9.13
Long Term Debt Payments
-0.51
-0.20%
-0.51
-14.83%
-0.45
+85.42%
-3.05
Net Long Term Debt Issuance
-0.51
-102.74%
18.71
+4304.94%
-0.45
-107.33%
6.07
Short Term Debt Payments
-4.50
+68.84%
-14.43
-835.39%
-1.54
—
Net Short Term Debt Issuance
-4.50
+68.84%
-14.43
-835.39%
-1.54
—
Net Common Stock Issuance
13.89
-15.06%
16.36
+16.10%
14.09
-1.88%
14.36
Proceeds From Stock Option Exercised
0.00
-100.00%
0.02
-99.26%
2.96
+59000.00%
0.01
Changes In Cash
-7.74
-225.59%
6.16
+200.83%
-6.11
-240.09%
-1.80
Effect Of Exchange Rate Changes
0.55
+2395.45%
0.02
+109.82%
-0.22
+63.10%
-0.61
Beginning Cash Position
10.44
+145.26%
4.25
-59.81%
10.59
-18.50%
12.99
End Cash Position
3.25
-68.86%
10.44
+145.26%
4.25
-59.81%
10.59
Free Cash Flow
-8.10
+81.56%
-43.93
-91.78%
-22.91
+13.75%
-26.56
Interest Paid Supplemental Data
1.27
-87.79%
10.39
+834.92%
1.11
+87.35%
0.59
Common Stock Issuance
13.89
-15.06%
16.36
+16.10%
14.09
-1.88%
14.36
Issuance Of Capital Stock
13.89
-15.06%
16.36
+16.10%
14.09
-1.88%
14.36
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category